Clinical Trials Directory

Trials / Unknown

UnknownNCT02672878

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI)

Prospective Study of Bioresorbable Vascular Scaffold Treatment in Patients With In-stent Restenosis

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
Spanish Society of Cardiology · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Treatment of patients with in-stent restenosis (ISR) remains a challenge. This study will assess the efficacy of Bioresorbable Vascular Scaffolds (BVS) (Abbott Vascular) in the treatment of patients suffering from ISR.

Detailed description

Treatment of patients with ISR remains a challenge. Currently both drug-eluting stents (DES) and drug-coated balloons (DCB) are considered as the strategies of choice in this setting. However, data on the value of BVS in patients with ISR is scarce. BVS are very effective to inhibit neointimal proliferation and they avoid the need of implanting a new permanent metal layer. Accordingly, currently, there is a major interest to elucidate the potential value of BVS in patients with ISR. This prospective Spanish multicenter study will assess the clinical and angiographic outcome of patients with ISR treated with BVS. BVS will be implanted in selected patients (fulfilling inclusion and exclusion criteria) presenting with either BMS-ISR or DES-ISR. Care will be paid to ensure device optimization. Angiographic follow-up will be obtained at 6-9 months. A centralized angiographic corelab will be used to provide QCA measurements. Clinical follow-up will be also obtained at 1 year and then yearly. Clinical events will be adjudicated by an independent Clinical Event Committee.

Conditions

Interventions

TypeNameDescription
DEVICEBioresorbable vascular scaffold

Timeline

Start date
2014-04-01
Primary completion
2016-12-01
Completion
2020-12-01
First posted
2016-02-03
Last updated
2017-02-23

Locations

19 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02672878. Inclusion in this directory is not an endorsement.

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) (NCT02672878) · Clinical Trials Directory